Free and open to the public, this community-centric event is modeled after the UW-Madison School of Medicine and Public Health’s “Mini-Med School” programs. Our fall 2017 Saving Sight Session will feature the leading research from Julie Mares, PhD, Professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin. Please join us for this exciting discussion and light dinner.
Dr. Mares will be presenting, “What are plant pigments doing in our eyes? What can they tell us?”
CLICK HERE TO REGISTER BY OCTOBER 20th
About Dr. Mares’s Research
Dr. Julie Mares focuses her research on how lifestyle and dietary practices can affect eye health as we age. Her research looks at how, why and what lifestyle and dietary practices can influence the aging of our eyes, and eye conditions that commonly compromise vision as we age, such as macular degeneration and diabetic retinopathy.
Dr. Mares’ research findings suggest practical recommendations for healthy living at any age, involving the food we eat, exercises we can do and dietary supplements that may help or harm us along the way.
Currently, Dr. Mares is currently a professor at the University of Wisconsin Department of Ophthalmology and Visual Science and a member of the Nelson Institute of Environmental Studies and University of Wisconsin Institute on Aging.
Please join us, on October 26, 2017.
CLICK HERE TO REGISTER BY OCTOBER 20TH
Please join us for a collective exploration into the ever-changing landscape of sight saving discovery with colleagues and peers from across the globe.
Our next discussion will feature James Tahara Handa, MD, Robert Bond Welch, MD, Professor, Professor of Ophthalmology at Wilmer Eye Institute of Johns Hopkins University.
About Dr. Handa
Dr. Handa is the Robert Bond Welch, MD, Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval.